Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Cole

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumorsElizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Mutation Research|June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administrationV Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
Blood|April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacyWyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumorsElizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Mutation Research|June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administrationV Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
Blood|April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacyWyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Pageof 2